What's 200,000? There are medical representatives with an advance of 3 million

There are pharmaceutical representatives, advance capital of more than 3 million recently, the industry is hotly discussing the issue of pharmaceutical representatives advance capital, there are pharmaceutical representatives said that in a small pharmaceutical company pad more than 3 million, and is selling cars to sell housing mats into.
fact, the topic of the article Seber blue has also been reported before.
remember a while ago the author wrote an article "there are medical representatives, advance capital of 200,000", when there are many readers at the end of the text message that this is simply a witch.
from the article more than a hundred messages, advance capital has almost become the medical representative of the common meal, the industry standard.
readers left a message that the medical representative advance is not the most terrible, terrible is the arrears of the return.
some representatives left office almost a year, the money has not returned, some enterprises will be on behalf of the monthly business growth assessment, if the assessment is not up to standard, the advance of a penny also do not give reimbursement.
from the listed pharmaceutical company sales cost composition, including sales staff compensation, day-to-day administrative costs, marketing and academic promotion.
market fees, conference fees, consulting fees are the main sales costs of the project.
the medical representative pad, many of which are actually in the scope of sales costs, some of which also include rebates to doctors.
in fact, since last year, there are pharmaceutical representatives to Seberan revealed that in the promotion process more and more advances, they handed in the invoice for reimbursement, but the cost of corporate reimbursement is late.
Recently, a number of listed pharmaceutical companies received a 2019 annual inquiry letter from Shenzhen Stock Exchange, asking for an explanation of the proportion of academic promotion fees in sales costs, whether the sales cost rate is at a reasonable level in the industry, and whether there are commercial bribery or to facilitate commercial bribery.
well known, with the "business reform increase" and "golden tax three" landing, tax collection and management more stringent, pharmaceutical companies also pay more attention to fiscal and tax issues.
this shows that the medical representative advance this problem, is likely to become a stealth "bomb", once "explosion", hurt their own at the same time, will also affect enterprises.
, how has become the target of public interest on October 20, China News Network WeChat Public published an article entitled "Hands off, medicine generation!" the article.
cites a case recently disclosed on the website of the State Supervision Commission of the Central Commission for Discipline Inspection, in which the staff of the original pharmacy department of the First People's Hospital of Hangzhou City, Zhejiang Province, used their position to facilitate the introduction of new drugs, drug procurement and other aspects of seeking benefits for drug dealers, illegally receiving kickbacks of more than 10.19 million yuan in bribery cases.
, only two drugs brought up to $3.25 million in "benefits" to the pharmacy staff.
drugmakers said they charge rebates of up to 40 per cent of the drug's retail price.
from this series of data, it seems really not impossible for pharmaceutical representatives to advance hundreds of thousands and millions.
Although there are indeed some non-compliance in the industry, but the author believes that, in fact, with the acceleration of the national medical anti-corruption process, there have been many pharmaceutical companies are in transition, from the original focus on gold sales gradually transformed into academic marketing.
many pharmaceutical representatives are not the salesmen who used to give doctors money, they are elites in their fields, and their academic knowledge of products is even more professional than that of experts.
medical representative is a formal occupation written into the General Code of Occupational Classification of the People's Republic of China, with a clear definition of occupation and work tasks.
we should reject bad things in the industry, but we shouldn't classify all medical representatives as targets for attack.
the long road of transformation of pharmaceutical representatives recently, it was reported that a hospital announced on the "prohibition of medical representatives six not allowed" provisions, medical representatives in the hospital activities to carry out strict control.
With the recent release of the National Health and Safety Commission "on the issuance of the 2020 medical industry style construction work special action plan notice", the hospital clean-up has been widely concerned, pharmaceutical representatives have once again become the focus of public opinion.
it is understood that the vast majority of hospitals are currently on high alert, some hospital department chiefs even directly notify medical representatives, from now on prohibited to the department, otherwise the consequences of their own.
hospitals have also issued "suspected medical equipment representative identification of the important."
ago, the industry from time to time out of the pharmaceutical representatives were arrested, taken away, related pharmaceutical companies were suspended from drugs and other news, so that many compliance pharmaceutical representatives simply do not work properly.
fact, medical representatives, as a profession recognized by the State, exist in contact with medical personnel.
The General Code of Occupational Classification of the People's Republic of China clearly stipulates that the tasks of pharmaceutical representatives include: 1, formulating plans and programs for the promotion of pharmaceutical products;
As early as February 9, 2017, the General Office of the State Council issued "Several Opinions on Further Reform and Improvement of the Policy on the Production and Circulation of Pharmaceuticals", which clearly stated that "we should strengthen the management of pharmaceutical representatives, establish a system for the registration and filing of pharmaceutical representatives, and make the information available to the public in a timely manner."
medical representatives can only engage in academic promotion, technical advice and other activities, may not undertake the task of drug sales, its loss of trust is recorded in the personal credit record."
September 30, this year, the State Drug Administration officially issued the "Pharmaceutical Representative Filing Management Measures (Trial)", and made it clear that the measures will be formally implemented from December 1.
it was re-emphasized that the pharmaceutical representative is not a salespable, and the term "pharmaceutical representative" as used in these Measures refers to a professional who, on behalf of the drug market license holder, is engaged in drug information transmission, communication and feedback within the territory of the People's Republic of China.
In addition, the method makes it clear that medical representatives may carry out academic promotion and other activities in the following forms: (1) to communicate in person with medical personnel and pharmaceutical personnel in medical institutions;
from a series of policies, there is no ban on compliance work of pharmaceutical representatives into the hospital to carry out academic promotion, technical advice and other work.
important role of pharmaceutical representatives in the industry as a bridge between pharmaceutical companies and doctors is irreplaceable.
fact, many clinicians believe that the new drug technology is very much in need of medical representatives to promote, but the role of pharmaceutical representatives needs to be transformed and upgraded.
original title: there are medical representatives, advance capital of 3 million